Vimarsana
Biggest News Aggregation in the World

Page 44 - Exact Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Science Today - Breaking & Trending Today

Exact Sciences announces third quarter 2021 results - Vimarsana News

Exact Sciences announces third quarter 2021 results

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $456.4 million for the third quarter ended September...

Exact Sciences to participate in November investor conferences - Vimarsana News

Exact Sciences to participate in November investor conferences

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors...

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening - Vimarsana News

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening - Vimarsana News

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient...

Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research - Vimarsana News

Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research

Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.